Liver biopsy assessment in chronic viral hepatitis: A personal, practical approach

Modern Pathology

Volumn 20, Issue 1 SUPPL., 2007, Pages

  Theise, Neil D ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Chronic hepatitis; Grading; Liver biopsy; Staging; Viral hepatitis

Indexed keywords

ALCOHOLIC FATTY LIVER; BATTS LUDWIG CLASSIFICATION; CHRONIC HEPATITIS; HEMOCHROMATOSIS; HEMOSIDEROSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATORY DISEASE; LIVER BIOPSY; LIVER NECROSIS; METAVIR SCORING SYSTEM; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; REVIEW; SCHEUER SCORING SYSTEM; SCORING SYSTEM; STEATOSIS; SUPERINFECTION;

ALGORITHMS; BIOPSY; HEPATITIS C, CHRONIC; HUMANS; LIVER; TERMINOLOGY;

EID: 34248355069     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800693     Document Type: Review

References (36)

1. De Groote J, Desmet VJ, Gedigk P, et al. A classification of chronic hepatitis. Lancet 1968;2:626-628.
2. Scheuer PJ. The nomenclature of chronic hepatitis: time for a change. J Hepatol 1995;22:112-114.
3. Gerber M. Chronic hepatitis C: the beginning of the end of a time-honored nomenclature? Hepatology 1992;15:733-734.
4. Hunt N, Fleming K. Reproducibility of liver biopsy grading and staging. Liver 1999;19:169-170.
5. Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 2000;31:241-246.
6. Scheuer PJ, Standish RA, Dhillon AP. Scoring of chronic hepatitis. Clin Liver Dis 2002;6:335-347.
7. Koukoulis G. Chronic hepatitis C: grading, staging, and searching for reliable predictors of outcome. Hum Pathol 2001;32:899-903.
8. Desmet VJ. Histological classification of chronic hepatitis. Acta Gastroenterol Belg 1997;60:259-267.
9. Ferrell L. Histological classification of chronic hepatitis. Acta Gastroenterol Belg 1997;60:259-267.
10. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699.
11. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-1520.
12. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-435.
13. Scheuer PJ. Classification of viral hepatitis: a need for reassessment. J Hepatol 1991;13:372-374.
14. Bedossa P, Bioulac-Sage P, Callard P, et al. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15-20.
15. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995;19:1409-1417.
16. Theise ND, Bodenheimer H, Ferrell L. Viral hepatitis. In: Burt A, Portmann B, Ferrell L (eds). MacSween's Pathology of the Liver, 5th edn. Churchill Livingston/Elsevier: London, UK, 2006 (in press).
17. Guido M, Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 2004;24:89-97.
18. Fanning L, Loane J, Kenny-Walsh E, et al. Tissue viral load variability in chronic hepatitis C. Am J Gastroenterol 2001;96:3384-3389.
19. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614-2618.
20. Persico M, Palmentieri B, Vecchione R, et al. Diagnosis of chronic liver disease: reproducibility and validation of liver biopsy. Am J Gastroenterol 2002;97:491-492.
21. Siddique I, El-Naga HA, Madda JP, et al. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol 2003;38:427-432.
22. Zekry A, McHutchison JG, Diehl AM. Insulin resistance and steatosis in hepatitis C virus infection. Gut 2005;54:903-906.
23. Lefkowitch JH. Hepatobiliary pathology. Curr Opin Gastroenterol 2006;22:198-208.
24. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43(2 Suppl 1):S99-S112.
25. Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis 2004;24:3-20.
26. Alla V, Bonkovsky HL. Iron in nonhemochromatotic liver disorders. Semin Liver Dis 2005;25:461-472.
27. Gattoni A, Parlato A, Vangieri B, et al. Role of hemochromatosis genes in chronic hepatitis C. Clin Ther 2006;157:61-68.
28. Brunt EM. Pathology of hepatic iron overload. Semin Liver Dis 2005;25:392-401.
29. Fiel MI, Schiano TD, Guido M, et al. Increased hepatic iron deposition resulting from treatment of chronic hepatitis C with ribavirin. Am J Clin Pathol 2000;113:35-39.
30. Libbrecht L, Desmet V, Roskams T. Preneoplastic lesions in human hepatocarcinogenesis. Liver Int 2005;25:16-27.
31. Wanless I, Callea R, Craig JR, et al. Terminology of nodular lesions of the liver: Recommendations of the World Congress of Gastroenterology Working Group. Hepatology 1995;22:983-993.
32. Borzio M, Bruno S, Roncalli M, et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis - a prospective study. Gastroenterology 1995;108:812-817.
33. Ganne-Carrie N, Chastang C, Chapel F, et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in western patients with cirrhosis. Hepatology 1996;23:1112-1118.
34. Marchio A, Terris B, Meddeb M, et al. Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation. J Clin Pathol-Mol Pathol 2001;54:270-274.
35. Theise ND. Cirrhosis and hepatocellular neoplasia: More like cousins than like parent and child. Gastroenterology 1996;111:526-528.
36. Vallet-Pichard A, Pol S. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection. J Hepatol 2006;44(1 Suppl):S28-S34.